Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Global Metabolic Disorders Treatment Industry Research Report, Growth Trends and Competitive Analysis 2023-2029

Global Metabolic Disorders Treatment Industry Research Report, Growth Trends and Competitive Analysis 2023-2029

Industry: Medical Care

Published: 2023-05-30

Pages: 107 Pages

Report ld: 663526

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.

Due to the COVID-19 pandemic, the global Metabolic Disorders Treatment market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Glycogen Metabolism Disease Drug accounting for % of the Metabolic Disorders Treatment global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Hospital segment is altered to an % CAGR throughout this forecast period.

The global key companies of Metabolic Disorders Treatment include Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Boehringer Ingelheim, KOWA, Kythera, Fuji yakuhin and LG Life Science, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

The United States Metabolic Disorders Treatment market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2029, trailing a CAGR of % through the analysis period. As for the Europe Metabolic Disorders Treatment landscape, Germany is projected to reach US$ million by 2029. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Metabolic Disorders Treatment market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Metabolic Disorders Treatment market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Metabolic Disorders Treatment market. Readers of the report can become informed about current and future trends of the global Metabolic Disorders Treatment market and how they will impact market growth during the forecast period.

Report Metric
Details
Report Title
Global Metabolic Disorders Treatment Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Market Size Available for Years
2023-2029
Global Metabolic Disorders Treatment Companies Covered
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Boehringer Ingelheim
KOWA
Kythera
Fuji yakuhin
LG Life Science
Metsubishi Tanabe Pharma
Global Metabolic Disorders Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Metabolic Disorders Treatment in global and regional level.
Chapter 3: Detailed analysis of Metabolic Disorders Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metabolic Disorders Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Metabolic Disorders Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Glycogen Metabolism Disease Drug
        1.2.3 Lipid Metabolism Disease Drug
        1.2.4 Amino Acid Metabolism Drug
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Metabolic Disorders Treatment Market Growth Rate by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Market Perspective
    2.1 Global Metabolic Disorders Treatment Market Size (2018-2029)
    2.2 Metabolic Disorders Treatment Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2029
    2.3 Global Metabolic Disorders Treatment Market Size by Region (2018-2023)
    2.4 Global Metabolic Disorders Treatment Market Size Forecast by Region (2024-2029)
    2.5 Global Top 10 Metabolic Disorders Treatment Countries Ranking by Market Size

3 Metabolic Disorders Treatment Competitive by Company
    3.1 Global Metabolic Disorders Treatment Revenue by Players
        3.1.1 Global Metabolic Disorders Treatment Revenue by Players (2018-2023)
        3.1.2 Global Metabolic Disorders Treatment Market Share by Players (2018-2023)
    3.2 Global Metabolic Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Company Covered: Ranking by Metabolic Disorders Treatment Revenue
    3.4 Global Metabolic Disorders Treatment Market Concentration Ratio
        3.4.1 Global Metabolic Disorders Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Metabolic Disorders Treatment Revenue in 2022
    3.5 Global Key Players of Metabolic Disorders Treatment Head office and Area Served
    3.6 Global Key Players of Metabolic Disorders Treatment, Product and Application
    3.7 Global Key Players of Metabolic Disorders Treatment, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

4 Global Metabolic Disorders Treatment Breakdown Data by Type
    4.1 Global Metabolic Disorders Treatment Historic Revenue by Type (2018-2023)
    4.2 Global Metabolic Disorders Treatment Forecasted Revenue by Type (2024-2029)

5 Global Metabolic Disorders Treatment Breakdown Data by Application
    5.1 Global Metabolic Disorders Treatment Historic Market Size by Application (2018-2023)
    5.2 Global Metabolic Disorders Treatment Forecasted Market Size by Application (2024-2029)

6 North America
    6.1 North America Metabolic Disorders Treatment Revenue by Company (2021-2023)
    6.2 North America Metabolic Disorders Treatment Revenue by Type (2018-2029)
    6.3 North America Metabolic Disorders Treatment Revenue by Application (2018-2029)
    6.4 North America Metabolic Disorders Treatment Revenue by Country (2018-2029)
        6.4.1 the United States
        6.4.2 Canada

7 Europe
    7.1 Europe Metabolic Disorders Treatment Revenue by Company (2021-2023)
    7.2 Europe Metabolic Disorders Treatment Revenue by Type (2018-2029)
    7.3 Europe Metabolic Disorders Treatment Revenue by Application (2018-2029)
    7.4 Europe Metabolic Disorders Treatment Revenue by Country (2018-2029)
        7.4.1 Germany
        7.4.2 France
        7.4.3 UK
        7.4.4 Italy
        7.4.5 Russia

8 Asia Pacific
    8.1 Asia Pacific Metabolic Disorders Treatment Revenue by Company (2021-2023)
    8.2 Asia Pacific Metabolic Disorders Treatment Revenue by Type (2018-2029)
    8.3 Asia Pacific Metabolic Disorders Treatment Revenue by Application (2018-2029)
    8.4 Asia Pacific Metabolic Disorders Treatment Revenue by Region (2018-2029)
        8.4.1 China
        8.4.2 Japan
        8.4.3 South Korea
        8.4.4 India
        8.4.5 Australia
        8.4.6 China Taiwan
        8.4.7 Indonesia
        8.4.8 Thailand
        8.4.9 Malaysia

9 Latin America
    9.1 Latin America Metabolic Disorders Treatment Revenue by Company (2021-2023)
    9.2 Latin America Metabolic Disorders Treatment Revenue by Type (2018-2029)
    9.3 Latin America Metabolic Disorders Treatment Revenue by Application (2018-2029)
    9.4 Latin America Metabolic Disorders Treatment Revenue by Country (2018-2029)
        9.4.1 Mexico
        9.4.2 Brazil
        9.4.3 Argentina

10 Middle East and Africa
    10.1 Middle East and Africa Metabolic Disorders Treatment Revenue by Company (2021-2023)
    10.2 Middle East and Africa Metabolic Disorders Treatment Revenue by Type (2018-2029)
    10.3 Middle East and Africa Metabolic Disorders Treatment Revenue by Application (2018-2029)
    10.4 Middle East and Africa Metabolic Disorders Treatment Revenue by Country (2018-2029)
        10.4.1 Turkey
        10.4.2 Saudi Arabia
        10.4.3 UAE

11 Company Profiles
    11.1 Merck
        11.1.1 Merck Company Details
        11.1.2 Merck Business Overview
        11.1.3 Merck Metabolic Disorders Treatment Products and Services
        11.1.4 Merck Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.1.5 Merck Metabolic Disorders Treatment SWOT Analysis
        11.1.6 Merck Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Metabolic Disorders Treatment Products and Services
        11.2.4 Novartis Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.2.5 Novartis Metabolic Disorders Treatment SWOT Analysis
        11.2.6 Novartis Recent Development
    11.3 Takeda Pharmaceutical
        11.3.1 Takeda Pharmaceutical Company Details
        11.3.2 Takeda Pharmaceutical Business Overview
        11.3.3 Takeda Pharmaceutical Metabolic Disorders Treatment Products and Services
        11.3.4 Takeda Pharmaceutical Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.3.5 Takeda Pharmaceutical Metabolic Disorders Treatment SWOT Analysis
        11.3.6 Takeda Pharmaceutical Recent Development
    11.4 Astra Zeneca
        11.4.1 Astra Zeneca Company Details
        11.4.2 Astra Zeneca Business Overview
        11.4.3 Astra Zeneca Metabolic Disorders Treatment Products and Services
        11.4.4 Astra Zeneca Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.4.5 Astra Zeneca Metabolic Disorders Treatment SWOT Analysis
        11.4.6 Astra Zeneca Recent Development
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Details
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Metabolic Disorders Treatment Products and Services
        11.5.4 Boehringer Ingelheim Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.5.5 Boehringer Ingelheim Metabolic Disorders Treatment SWOT Analysis
        11.5.6 Boehringer Ingelheim Recent Development
    11.6 KOWA
        11.6.1 KOWA Company Details
        11.6.2 KOWA Business Overview
        11.6.3 KOWA Metabolic Disorders Treatment Products and Services
        11.6.4 KOWA Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.6.5 KOWA Metabolic Disorders Treatment SWOT Analysis
        11.6.6 KOWA Recent Development
    11.7 Kythera
        11.7.1 Kythera Company Details
        11.7.2 Kythera Business Overview
        11.7.3 Kythera Metabolic Disorders Treatment Products and Services
        11.7.4 Kythera Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.7.5 Kythera Metabolic Disorders Treatment SWOT Analysis
        11.7.6 Kythera Recent Development
    11.8 Fuji yakuhin
        11.8.1 Fuji yakuhin Company Details
        11.8.2 Fuji yakuhin Business Overview
        11.8.3 Fuji yakuhin Metabolic Disorders Treatment Products and Services
        11.8.4 Fuji yakuhin Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.8.5 Fuji yakuhin Metabolic Disorders Treatment SWOT Analysis
        11.8.6 Fuji yakuhin Recent Development
    11.9 LG Life Science
        11.9.1 LG Life Science Company Details
        11.9.2 LG Life Science Business Overview
        11.9.3 LG Life Science Metabolic Disorders Treatment Products and Services
        11.9.4 LG Life Science Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.9.5 LG Life Science Metabolic Disorders Treatment SWOT Analysis
        11.9.6 LG Life Science Recent Development
    11.10 Metsubishi Tanabe Pharma
        11.10.1 Metsubishi Tanabe Pharma Company Details
        11.10.2 Metsubishi Tanabe Pharma Business Overview
        11.10.3 Metsubishi Tanabe Pharma Metabolic Disorders Treatment Products and Services
        11.10.4 Metsubishi Tanabe Pharma Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.10.5 Metsubishi Tanabe Pharma Metabolic Disorders Treatment SWOT Analysis
        11.10.6 Metsubishi Tanabe Pharma Recent Development

12 Metabolic Disorders Treatment Market Dynamics
    12.1 Metabolic Disorders Treatment Industry Trends
    12.2 Metabolic Disorders Treatment Market Drivers
    12.3 Metabolic Disorders Treatment Market Challenges
    12.4 Metabolic Disorders Treatment Market Restraints

13 Research Findings and Conclusion

14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details

Table of Figures

List of Tables
    Table 1. Global Metabolic Disorders Treatment Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Glycogen Metabolism Disease Drug
    Table 3. Key Players of Lipid Metabolism Disease Drug
    Table 4. Key Players of Amino Acid Metabolism Drug
    Table 5. Key Players of Other
    Table 6. Global Metabolic Disorders Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 7. Global Metabolic Disorders Treatment Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
    Table 8. Global Metabolic Disorders Treatment Revenue by Region (2018-2023) & (US$ Million)
    Table 9. Global Metabolic Disorders Treatment Revenue Forecast by Region (2024-2029) & (US$ Million)
    Table 10. Global Metabolic Disorders Treatment Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
    Table 11. Global Metabolic Disorders Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 12. Global Metabolic Disorders Treatment Market Share by Players (2018-2023)
    Table 13. Global Top Metabolic Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disorders Treatment as of 2022)
    Table 14. Ranking of Global Top Metabolic Disorders Treatment Companies by Revenue (US$ Million) in 2022
    Table 15. Global 5 Largest Players Market Share by Metabolic Disorders Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 16. Global Key Players of Metabolic Disorders Treatment, Headquarters and Area Served
    Table 17. Global Key Players of Metabolic Disorders Treatment, Product and Application
    Table 18. Global Key Players of Metabolic Disorders Treatment, Date of Enter into This Industry
    Table 19. Mergers & Acquisitions, Expansion Plans
    Table 20. Global Metabolic Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 21. Global Metabolic Disorders Treatment Revenue Market Share by Type (2018-2023)
    Table 22. Global Metabolic Disorders Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 23. Global Metabolic Disorders Treatment Revenue Market Share by Type (2024-2029)
    Table 24. Global Metabolic Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 25. Global Metabolic Disorders Treatment Revenue Market Share by Application (2018-2023)
    Table 26. Global Metabolic Disorders Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 27. Global Metabolic Disorders Treatment Revenue Market Share by Application (2024-2029)
    Table 28. North America Metabolic Disorders Treatment Revenue by Company (2021-2023) & (US$ Million)
    Table 29. North America Metabolic Disorders Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 30. North America Metabolic Disorders Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 31. North America Metabolic Disorders Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 32. North America Metabolic Disorders Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 33. North America Metabolic Disorders Treatment Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 34. North America Metabolic Disorders Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 35. North America Metabolic Disorders Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 36. Europe Metabolic Disorders Treatment Revenue by Company (2021-2023) & (US$ Million)
    Table 37. Europe Metabolic Disorders Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 38. Europe Metabolic Disorders Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 39. Europe Metabolic Disorders Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 40. Europe Metabolic Disorders Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 41. Europe Metabolic Disorders Treatment Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Europe Metabolic Disorders Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 43. Europe Metabolic Disorders Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 44. Asia Pacific Metabolic Disorders Treatment Revenue by Company (2021-2023) & (US$ Million)
    Table 45. Asia Pacific Metabolic Disorders Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 46. Asia Pacific Metabolic Disorders Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 47. Asia Pacific Metabolic Disorders Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 48. Asia Pacific Metabolic Disorders Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 49. Asia-Pacific Metabolic Disorders Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 50. Asia Pacific Metabolic Disorders Treatment Revenue by Region (2018-2023) & (US$ Million)
    Table 51. Asia Pacific Metabolic Disorders Treatment Revenue by Region (2024-2029) & (US$ Million)
    Table 52. Latin America Metabolic Disorders Treatment Revenue by Company (2021-2023) & (US$ Million)
    Table 53. Latin America Metabolic Disorders Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 54. Latin America Metabolic Disorders Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 55. Latin America Metabolic Disorders Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 56. Latin America Metabolic Disorders Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 57. Latin America Metabolic Disorders Treatment Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 58. Latin America Metabolic Disorders Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 59. Latin America Metabolic Disorders Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 60. Middle East and Africa Metabolic Disorders Treatment Revenue by Company (2021-2023) & (US$ Million)
    Table 61. Middle East and Africa Metabolic Disorders Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 62. Middle East and Africa Metabolic Disorders Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 63. Middle East and Africa Metabolic Disorders Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 64. Middle East and Africa Metabolic Disorders Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 65. Middle East and Africa Metabolic Disorders Treatment Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 66. Middle East and Africa Metabolic Disorders Treatment Revenue by Country (2018-2023) & (US$ Million)
    Table 67. Middle East and Africa Metabolic Disorders Treatment Revenue by Country (2024-2029) & (US$ Million)
    Table 68. Merck Company Details
    Table 69. Merck Business Overview
    Table 70. Merck Metabolic Disorders Treatment Product and Services
    Table 71. Merck Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 72. Merck Metabolic Disorders Treatment SWOT Analysis
    Table 73. Merck Recent Development
    Table 74. Novartis Company Details
    Table 75. Novartis Business Overview
    Table 76. Novartis Metabolic Disorders Treatment Product and Services
    Table 77. Novartis Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 78. Novartis Metabolic Disorders Treatment SWOT Analysis
    Table 79. Novartis Recent Development
    Table 80. Takeda Pharmaceutical Company Details
    Table 81. Takeda Pharmaceutical Business Overview
    Table 82. Takeda Pharmaceutical Metabolic Disorders Treatment Product and Services
    Table 83. Takeda Pharmaceutical Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 84. Takeda Pharmaceutical Metabolic Disorders Treatment SWOT Analysis
    Table 85. Takeda Pharmaceutical Recent Development
    Table 86. Astra Zeneca Company Details
    Table 87. Astra Zeneca Business Overview
    Table 88. Astra Zeneca Metabolic Disorders Treatment Product and Services
    Table 89. Astra Zeneca Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 90. Astra Zeneca Metabolic Disorders Treatment SWOT Analysis
    Table 91. Astra Zeneca Recent Development
    Table 92. Boehringer Ingelheim Company Details
    Table 93. Boehringer Ingelheim Business Overview
    Table 94. Boehringer Ingelheim Metabolic Disorders Treatment Product and Services
    Table 95. Boehringer Ingelheim Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 96. Boehringer Ingelheim Metabolic Disorders Treatment SWOT Analysis
    Table 97. Boehringer Ingelheim Recent Development
    Table 98. KOWA Company Details
    Table 99. KOWA Business Overview
    Table 100. KOWA Metabolic Disorders Treatment Product and Services
    Table 101. KOWA Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 102. KOWA Metabolic Disorders Treatment SWOT Analysis
    Table 103. KOWA Recent Development
    Table 104. Kythera Company Details
    Table 105. Kythera Business Overview
    Table 106. Kythera Metabolic Disorders Treatment Product and Services
    Table 107. Kythera Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 108. Kythera Metabolic Disorders Treatment SWOT Analysis
    Table 109. Kythera Recent Development
    Table 110. Fuji yakuhin Company Details
    Table 111. Fuji yakuhin Business Overview
    Table 112. Fuji yakuhin Metabolic Disorders Treatment Product and Services
    Table 113. Fuji yakuhin Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 114. Fuji yakuhin Metabolic Disorders Treatment SWOT Analysis
    Table 115. Fuji yakuhin Recent Development
    Table 116. LG Life Science Company Details
    Table 117. LG Life Science Business Overview
    Table 118. LG Life Science Metabolic Disorders Treatment Product and Services
    Table 119. LG Life Science Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 120. LG Life Science Metabolic Disorders Treatment SWOT Analysis
    Table 121. LG Life Science Recent Development
    Table 122. Metsubishi Tanabe Pharma Company Details
    Table 123. Metsubishi Tanabe Pharma Business Overview
    Table 124. Metsubishi Tanabe Pharma Metabolic Disorders Treatment Product and Services
    Table 125. Metsubishi Tanabe Pharma Metabolic Disorders Treatment Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 126. Metsubishi Tanabe Pharma Metabolic Disorders Treatment SWOT Analysis
    Table 127. Metsubishi Tanabe Pharma Recent Development
    Table 128. Metabolic Disorders Treatment Market Trends
    Table 129. Metabolic Disorders Treatment Market Drivers
    Table 130. Metabolic Disorders Treatment Market Challenges
    Table 131. Metabolic Disorders Treatment Market Restraints
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Metabolic Disorders Treatment Product Picture
    Figure 2. Global Metabolic Disorders Treatment Market Size by Type (US$ Million): 2018 VS 2022 VS 2029
    Figure 3. Global Metabolic Disorders Treatment Market Share by Type: 2022 VS 2029
    Figure 4. Glycogen Metabolism Disease Drug Features
    Figure 5. Lipid Metabolism Disease Drug Features
    Figure 6. Amino Acid Metabolism Drug Features
    Figure 7. Other Features
    Figure 8. Global Metabolic Disorders Treatment Market Size by Application (US$ Million): 2018 VS 2022 VS 2029
    Figure 9. Global Metabolic Disorders Treatment Market Share by Application: 2022 VS 2029
    Figure 10. Hospital
    Figure 11. Retail Pharmacy
    Figure 12. Metabolic Disorders Treatment Report Years Considered
    Figure 13. Global Metabolic Disorders Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Metabolic Disorders Treatment Market Size 2018-2029 (US$ Million)
    Figure 15. Global Metabolic Disorders Treatment Market Size Market Share by Region: 2022 VS 2029
    Figure 16. Global Metabolic Disorders Treatment Revenue Market Share by Region in 2018 VS 2022
    Figure 17. Global Metabolic Disorders Treatment Revenue Market Share Forecast by Region (2024-2029)
    Figure 18. Global Top 10 Metabolic Disorders Treatment Countries Ranking by Market Size (US$ Million) in 2022
    Figure 19. Global Metabolic Disorders Treatment Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
    Figure 20. Global Metabolic Disorders Treatment Market Share by Players in 2022
    Figure 21. Global Top Metabolic Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disorders Treatment as of 2022)
    Figure 22. The Top 10 and 5 Players Market Share by Metabolic Disorders Treatment Revenue in 2022
    Figure 23. North America Metabolic Disorders Treatment Revenue Market Share by Company in 2022
    Figure 24. North America Metabolic Disorders Treatment Revenue Market Share by Type (2018-2029)
    Figure 25. North America Metabolic Disorders Treatment Revenue Market Share by Application (2018-2029)
    Figure 26. North America Metabolic Disorders Treatment Revenue Share by Country (2018-2029)
    Figure 27. the United States Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 28. Canada Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 29. Europe Metabolic Disorders Treatment Revenue Market Share by Company in 2022
    Figure 30. Europe Metabolic Disorders Treatment Revenue Market Share by Type (2018-2029)
    Figure 31. Europe Metabolic Disorders Treatment Revenue Market Share by Application (2018-2029)
    Figure 32. Europe Metabolic Disorders Treatment Revenue Share by Country (2018-2029)
    Figure 33. Germany Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 34. France Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 35. UK Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 36. Italy Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 37. Russia Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 38. Asia Pacific Metabolic Disorders Treatment Revenue Market Share by Company in 2022
    Figure 39. Asia Pacific Metabolic Disorders Treatment Revenue Market Share by Type (2018-2029)
    Figure 40. Asia Pacific Metabolic Disorders Treatment Revenue Market Share by Application (2018-2029)
    Figure 41. Asia Pacific Metabolic Disorders Treatment Revenue Share by Region (2018-2029)
    Figure 42. China Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 43. Japan Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 44. South Korea Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 45. India Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 46. Australia Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 47. China Taiwan Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 48. Indonesia Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 49. Thailand Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 50. Malaysia Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 51. Latin America Metabolic Disorders Treatment Revenue Market Share by Company in 2022
    Figure 52. Latin America Metabolic Disorders Treatment Revenue Market Share by Type (2018-2029)
    Figure 53. Latin America Metabolic Disorders Treatment Revenue Market Share by Application (2018-2029)
    Figure 54. Latin America Metabolic Disorders Treatment Revenue Share by Country (2018-2029)
    Figure 55. Mexico Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 56. Brazil Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 57. Argentina Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 58. Middle East and Africa Metabolic Disorders Treatment Revenue Market Share by Company in 2022
    Figure 59. Middle East and Africa Metabolic Disorders Treatment Revenue Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Metabolic Disorders Treatment Revenue Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Metabolic Disorders Treatment Revenue Share by Country (2018-2029)
    Figure 62. Turkey Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 63. Saudi Arabia Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 64. UAE Metabolic Disorders Treatment Revenue (2018-2029) & (US$ Million)
    Figure 65. Merck Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 66. Novartis Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 67. Takeda Pharmaceutical Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 68. Astra Zeneca Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 69. Boehringer Ingelheim Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 70. KOWA Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 71. Kythera Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 72. Fuji yakuhin Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 73. LG Life Science Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 74. Metsubishi Tanabe Pharma Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed

Description

Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.

Due to the COVID-19 pandemic, the global Metabolic Disorders Treatment market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Glycogen Metabolism Disease Drug accounting for % of the Metabolic Disorders Treatment global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Hospital segment is altered to an % CAGR throughout this forecast period.

Related Reports

Global Metabolic Disorders Treatment Market Research Report 2023
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-07-25
Pages: 86
USD 2900.00
(Single User License)
Global Metabolic Disorders Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-07-25
Pages: 104
USD 3350.00
(Single User License)
Global Metabolic Disorders Treatment Market Insights, Forecast to 2029
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-08-28
Pages: 105
USD 4900.00
(Single User License)
Metabolic Disorders Treatment - Global Market Insights and Sales Trends 2024
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-11-15
Pages: 102
USD 3350.00
(Single User License)
Global Metabolic Disorders Treatment Market Research Report 2024
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2024-01-05
Pages: 87
USD 2900.00
(Single User License)
Metabolic Disorders Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2024-01-24
Pages: 115
USD 3950.00
(Single User License)
Global Metabolic Disorders Treatment Market Insights, Forecast to 2030
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2024-04-25
Pages: 105
USD 4900.00
(Single User License)
Global Metabolic Disorders Treatment Market Research Report 2025
The global market for Metabolic Disorders Treatment was valued at US$ 98580 million in the year 2024
Published: 2025-02-27
Pages: 76
USD 2900.00
(Single User License)
Metabolic Disorders Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Metabolic Disorders Treatment was estimated to be worth US$ 98580 million in 2
Published: 2025-02-27
Pages: 98
USD 3950.00
(Single User License)